Start Date
October 31, 2008
Study Completion Date
October 31, 2008
NEBIDO
Patients will receive 54 weeks of treatment with Nebido, 5 intramuscular injections of 4ml Nebido (at baseline, week 6, 18, 30, 42)
PLACEBO
Patients will receive 54 weeks of treatment with placebo, 5 intramuscular injections of 4ml placebo (at baseline, week 6, 18, 30, 42)
Milan
Bonn
Napoli
Moscow
Moscow
Saint Petersburg
Volgograd
Novosibirsk
Halle
Roma
Riga
Lodz
Warsaw
Warsaw
Warsaw
Wroclaw
Reading
London
London
Manchester
Lichfield
Glasgow
Birmingham
Cardiff
Chorley
Lead Sponsor
Bayer
INDUSTRY